A double-blind controlled trial of recombinant interferon-α2b in haemodialysis patients with chronic Hepatitis C Virus infection and abnormal aminotransferase levels

Journal of Viral Hepatitis

Volumn 4, Issue 2, 1997, Pages 113-119

  Fernandez J L ^a,c   Rendo, P ^a   Del Pino, N ^a   Viola, L ^b   Cavalli, Néstor ^c   Cusumano, Ana ^c   Digioia, María ^c   Molteni, Jorge Laborda ^c   Lef, Leonardo ^c   Nader, Emilia ^c   Otino, Fernando ^c   Santos, Juan Carlos ^c   Zucchini, Alfredo ^c  

^a Bio Sidus   (Argentina)

^b Clinica y Maternidad Suizo Argentina   (Argentina)

^c Constitución 4234 ^*

Author keywords

Haemodialysis; Hepatitis C; Interferon 2b

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA2B INTERFERON; ANTIVIRUS AGENT; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GENETICS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; VIROLOGY;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; CHRONIC DISEASE; DOUBLE-BLIND METHOD; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON ALFA-2B; MALE; MIDDLE AGED; RENAL DIALYSIS; RNA, VIRAL;

EID: 0031091154     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2893.1997.tb00213.x     Document Type: Article

References (22)

1. Roth D. Hepatitis C virus: The nephrologist's view. Am J Kidney Dis 1995; 25: 3-16.
2. Viola L, Pimentel E, Morgante P, Fernández JL. Are hepatitis C virus antibodies involved in chronic liver disease other than non-A, non-B hepatitis? [Letter]. Hepatology 1991; 13: 1303-1304.
3. Chan TM, Lok ASF, Cheng IKP, Chan RT. Prevalence of hepatitis C virus infection in hemodialysis patients: A longitudinal study comparing the results of RNA and antibody assays. Hepatology 1993; 17: 5-8.
4. Caramelo C, Ortiz A, Aguilera B et al. Liver disease patterns in hemodialysis patients with antibodies to hepatitis C virus. Am J Kidney Dis 1993; 22: 822-828.
5. Terrault N, Wright T. Interferon and hepatitis C. N Engl J Med 1995; 332: 1509-1511.
6. Ellis ME, Alfurayh O, Halim MA et al. Chronic non-A, non-B hepatitis complicated by end-stage renal failure treated with recombinant interferon alpha. J Hepatol 1993; 18: 210-216.
7. Casanovas Taltavull T, Baliellas C, Sesé E et al. Interferon may be useful in hemodialysis patients with HCV chronic infection who are candidates to kidney transplant [Abstract]. Hepatology 1994; 20: 337A.
8. Koenig P, Vogel W, Umlauft F et al. Interferon treatment for chronic hepatitis C virus infection in uremic patients. Kidney Int 1994; 45: 1507-1509.
9. Pol S, Thiers V, Carnot F et al. Efficacy and tolerance of α-2b interferon therapy on HCV infection of hemodialyzed patients. Kidney Int 1995; 47: 1412-1418.
10. Miller AB, Hoogstraten B, Straquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207-214.
11. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
12. Tanno H, Fernández JL, Rendo P et al. Hepatitis C virus RNA and long-term response to recombinant interferon-α2b in patients with chronic hepatitis C. J Viral Hep 1995; 2: 97-102.
13. McOmish F, Yap L, Dow BC et al. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol 1994; 32: 884-892.
14. Steinberg D, Colla P. LOGIT: A supplementary module for SYSTAT. SYSTAT Inc. Evanson, IL, 1991.
15. Van Thiel DH, Caraceni P, Molloy PJ et al. Chronic hepatitis C in patients with normal or near normal alanine aminotransferase levels: the role of interferon α2b therapy. J Hepatol 1995; 23: 503-508.
16. 2b in patients with acute transfusion-associated hepatitis C. Hepatology 1994; 19: 19-22.
17. Gordge MP, Faint RW, Rylance PB, Neild GH. Platelet function and the bleeding time in progressive renal failure. Thromb Haemost 1988; 60: 83-87.
18. Viola L, Fernández JL, Cavalli N, Giulioni P, del Pino N. Hepatitis C virus antibodies in hemodialysis patients and its relationship with aminotransferase levels and liver histology [Abstract]. Scientific Program and Abstract Volume of the International Symposium on Viral Hepatitis and Liver Disease. Tokyo, Japan. May 10-14, 1993.
19. Fernández J, Giulioni P, del Pino N et al. Infección por el virus de la hepatitis C en pacientes de hemodiálisis: hallazgos epidemiológicos, clínicos e histológicos. Nefrología 1996; 16: 353-358.
20. Marcellin P, Poutaeu M, Boyer N et al. Usefulness of prolonging interferon therapy according to the initial response in patients with chronic hepatitis C without cirrhosis [Abstract]. Hepatology 1994; 20: 154A.
21. Roffi L, Colloredo Mels G, Antonelli G et al. Breakthrough during recombinant interferon alfa therapy in patients with chronic hepatitis C virus infection: prevalence, etiology, and management. Hepatology 1995; 21: 645-649.
22. Lau JYN, Mizokami M, Ohno T, Diamond DA, Kniffen J, Davis GL. Discrepancy between biochemical and virological responses to interferon-α in chronic hepatitis C. Lancet 1993; 342: 1208-1209.